Editorial highlights dynamic weight-loss velocity over static BMI in gastric cancer, indicating improved prognostic utility and targeted nutritional intervention.
Key Points
Evaluate whether dynamic weight-loss velocity provides superior prognostic and actionable clinical utility compared to static body mass index measurements in gastric cancer.
Critical appraisal of clinical evidence evaluating time-dependent changes in body mass index versus static baseline metrics in gastric cancer cohorts.
Conceptual evaluation of longitudinal surveillance models for detecting malnutrition and timing therapeutic nutritional interventions.
Dynamic monitoring of weight-loss velocity provides earlier and more accurate prognostic insight into patient outcomes than isolated static body mass index values.
Longitudinal nutritional tracking establishes an actionable trigger for proactive supportive care and early metabolic intervention.